Photo via Benzinga
Healthcare technology company Phreesia, Inc. is facing a class action lawsuit filed by Bronstein, Gewirtz & Grossman LLC, a nationally recognized investor-rights law firm, according to announcements from May 17, 2026. The suit alleges that company leadership made materially false statements or omitted critical information that harmed shareholders who purchased stock during a specific 10-month window.
The complaint centers on claims that Phreesia management concealed slowing customer demand and reduced visibility into major revenue streams throughout the Class Period, which ran from May 8, 2025, through March 30, 2026. According to the filing, investors relied on incomplete or inaccurate disclosures when making decisions about purchasing or holding the company's securities on the New York Stock Exchange under ticker symbol PHR.
For Nashville-area healthcare providers and business professionals who may hold Phreesia stock in retirement accounts or investment portfolios, the lawsuit raises questions about disclosure practices among publicly traded healthcare software vendors. The company's platform serves medical practices and health systems across the country, making it relevant to local healthcare industry operations.
Investors who purchased Phreesia shares during the Class Period are encouraged to contact the law firm or visit its website to evaluate their potential participation in the case. The lawsuit represents an important reminder for healthcare executives to scrutinize vendor stability and financial disclosures when selecting partners for critical practice management systems.
